F15 documentation starts with clinical specificity
ICD-10-CM code family F15 is used for other stimulant-related disorders, including stimulant abuse, stimulant dependence, and unspecified stimulant use categories. For behavioral health clinicians, the documentation task is not just naming the code family. The note should support the clinical picture: the stimulant involved when known, the client’s reported pattern of use, observed symptoms, functional impact, risk considerations, interventions provided, and the plan for follow-up.
Diagnosis selection remains the clinician’s responsibility. AutoNotes does not assign diagnoses, determine medical necessity, or decide which ICD-10-CM code belongs in the record. Its role is documentation support: helping clinicians create structured, editable drafts that reflect the information they enter and the clinical framework they choose.
For example, a therapy note for a client reporting non-prescribed stimulant use before work may need different documentation than a crisis visit involving intoxication, agitation, paranoia, or sleep deprivation. Both may fall near the F15 code family, but the note should make the clinical differences clear.
How the F15 code family is commonly used in behavioral health records
In U.S. clinical documentation, ICD-10-CM codes under F15 generally relate to “other stimulant” conditions. This can include substances such as amphetamine-type stimulants, methamphetamine, and other stimulants not classified under cocaine-related disorders. Some F15 descriptions also reference caffeine-related conditions, depending on the specific code and coding context.
Clinicians may encounter F15-related documentation in several care settings:
- Outpatient therapy with co-occurring stimulant use and anxiety, depression, trauma symptoms, or sleep disruption.
- Substance use counseling where stimulant use is a primary treatment focus.
- Psychiatric evaluation when stimulant use may affect mood, psychosis, attention, or medication planning.
- Intake assessments that include diagnostic history, current use patterns, and readiness for change.
The F15 family includes more specific options than the broad category alone. Documentation may need to distinguish abuse, dependence, remission status, intoxication, withdrawal, and stimulant-induced conditions when clinically applicable. Because coding requirements vary by payer, setting, and billing workflow, clinicians should follow their organization’s policies and current code set resources.
What “other stimulant abuse” documentation should usually clarify
A progress note does not need to read like a coding manual. It does need enough detail for another treating professional to understand the client’s presentation, the clinical reasoning, and the care provided. For F15-related concerns, vague wording such as “substance issue discussed” may not be enough.
Useful documentation often includes these elements:
- Substance and route when known: prescribed stimulant misuse, non-prescribed stimulant use, methamphetamine use, excessive caffeine use, or unknown stimulant type.
- Pattern of use: frequency, amount when clinically relevant, duration, recent escalation, last reported use, and periods of abstinence.
- Clinical effects: sleep disruption, appetite changes, anxiety, irritability, mood changes, paranoia, hallucinations, impaired concentration, or withdrawal symptoms.
- Functional impact: missed work, relationship conflict, legal issues, financial strain, parenting concerns, academic problems, or medical concerns.
Risk documentation also matters. If the session includes intoxication, agitation, suicidal ideation, homicidal ideation, psychosis, unsafe driving, domestic conflict, or medical symptoms, the note should describe assessment findings and the clinician’s response. That may include safety planning, higher level of care discussion, crisis resources, coordination with prescribers, or referral for medical evaluation.
Progress note examples for F15-related sessions
The exact format depends on your practice, payer, and clinical model. The examples below are not diagnosis recommendations. They show how a clinician might document relevant details in a structured way while preserving clinical judgment.
SOAP note documentation example
Subjective: Client reported using non-prescribed stimulant pills three times in the past week to stay awake for night shifts. Client described sleeping 3–4 hours per night, increased anxiety, and conflict with partner related to irritability. Client denied suicidal or homicidal ideation.
Objective: Client appeared restless and spoke rapidly at times. Thought process was logical and goal-directed. No hallucinations or delusional content observed during session. Client was oriented to person, place, time, and situation.
Assessment: Stimulant use appears associated with sleep disruption, increased anxiety, and interpersonal impairment. Client demonstrated partial insight and expressed ambivalence about stopping use due to work demands. No acute safety concerns reported or observed during session.
Plan: Clinician provided motivational interviewing, explored triggers for use, reviewed sleep hygiene strategies, and discussed safer alternatives for fatigue management. Client agreed to track use, sleep, and anxiety symptoms before next session. Follow-up scheduled for one week.
DAP note documentation example
Data: Client reported recent methamphetamine use after two months without use. Client identified loneliness and contact with a prior peer group as triggers. Client reported shame, low mood, and reduced appetite. Client denied current suicidal intent and agreed to contact crisis support if risk increases.
Assessment: Relapse appears connected to social triggers and limited coping support during evenings. Client was engaged, tearful, and able to identify two protective factors. Continued outpatient treatment appears appropriate based on current presentation, with monitoring of mood and safety.
Plan: Session focused on relapse prevention planning, coping skills rehearsal, and identifying sober supports. Clinician and client updated the treatment plan objective related to reducing stimulant use and increasing support contact. Next session will review trigger log and support outreach.
How F15-related concerns may affect treatment planning
Treatment planning should connect the stimulant-related concern to measurable goals, clinical interventions, and client-specific barriers. A generic goal such as “stop using substances” may be too broad for a useful plan. More specific treatment planning gives the clinician and client a clearer way to review progress.
Possible treatment plan focus areas include:
- Use reduction or abstinence goals: reduce stimulant use from daily to two or fewer days per week, maintain abstinence for 30 days, or create a relapse prevention plan.
- Trigger identification: track high-risk times, people, emotions, settings, and cognitive patterns associated with use.
- Coping and replacement behaviors: practice grounding skills, sleep routines, support calls, urge surfing, or problem-solving around work fatigue.
- Co-occurring symptoms: address anxiety, depression, trauma symptoms, psychosis history, attention concerns, or insomnia when clinically relevant.
The interventions should match the clinician’s scope and the client’s needs. A therapist may document motivational interviewing, CBT, relapse prevention, psychoeducation, safety planning, or coordination of care. A psychiatric provider may also document medication considerations, stimulant prescription review, differential diagnosis, or monitoring for stimulant-induced symptoms.
Common documentation gaps with stimulant-related presentations
Many F15-related notes become difficult to support because the clinical details are scattered or implied. A clinician may have completed strong work in session, but the note only says, “Discussed substance use and coping skills.” That wording does not show the client’s presentation, the intervention, or the response.
Watch for these common gaps:
- No timeline: the note mentions stimulant use but does not state recent use, last use, frequency, or change since the prior visit.
- No impairment: the note does not connect use to functioning, symptoms, relationships, work, school, legal issues, or health concerns.
- No risk assessment: the note omits safety findings when the client presents with intoxication, paranoia, severe insomnia, or agitation.
- No treatment link: the note lists a diagnosis but does not connect interventions to treatment plan goals.
One practical fix is to use a consistent documentation prompt for stimulant-related sessions. For instance: “What substance was discussed, what changed since last session, what symptoms or impairment were present, what intervention was provided, how did the client respond, and what is the next clinical step?”
ICD-10-CM specificity and clinician review
F15 is a code family, not a complete clinical narrative. In many documentation workflows, a more specific ICD-10-CM code may be needed to reflect the selected diagnosis, remission status, intoxication, withdrawal, or stimulant-induced condition. The clinician should confirm the code in the current ICD-10-CM resource used by the practice, EHR, billing team, or payer.
Documentation should avoid overstating certainty. If the clinician is still assessing whether symptoms are substance-induced, related to another mental health condition, medication-related, or due to another medical factor, the note can reflect that clinical uncertainty. For example, “Client reports increased anxiety and insomnia following stimulant use; clinician will continue to assess relationship between stimulant use, work stress, and baseline anxiety symptoms.”
This distinction matters in behavioral health. Stimulant use can overlap with panic symptoms, bipolar-spectrum presentations, psychosis, ADHD medication concerns, trauma-related hyperarousal, and sleep disorders. Good documentation shows what the clinician assessed, what was observed, what the client reported, and what remains under review.
How AutoNotes supports F15-related documentation without assigning diagnoses
AutoNotes helps clinicians turn session details into structured, editable progress note drafts. For F15-related concerns, that can mean capturing the client’s reported use pattern, symptoms, impairment, interventions, response, risk assessment, and plan in a format such as SOAP, DAP, intake, assessment, or treatment planning documentation.
The clinician stays in control. AutoNotes does not replace diagnostic reasoning, choose the ICD-10-CM code, or finalize the record without review. Instead, it gives the clinician a cleaner starting point than a blank note or a generic AI writing tool.
Compared with copying forward old notes, AutoNotes can help reduce repeated language and prompt the clinician to document session-specific details. Compared with generic AI tools, AutoNotes is built around behavioral health workflows, including therapy progress notes, group notes, treatment plans, intakes, and clinical documentation patterns used by mental health professionals.
Practical workflow for documenting an F15-related session
A structured workflow can make stimulant-related documentation faster without making the note feel mechanical. After the session, gather the core details before drafting. This reduces the chance of leaving out risk, functional impact, or client response.
- Confirm the clinical focus: Was stimulant use the primary session focus, a secondary concern, or part of a broader co-occurring presentation?
- Record the client’s report: Include type of stimulant when known, pattern of use, last use, cravings, triggers, and any change since the prior session.
- Document assessment findings: Note mood, affect, thought process, orientation, psychosis indicators, intoxication concerns, withdrawal concerns, and safety assessment when relevant.
- Link intervention to the plan: Connect motivational interviewing, CBT, relapse prevention, psychoeducation, or coordination of care to the treatment goal.
Before signing, review the diagnosis field, code specificity, payer requirements, and clinical wording. Make sure the note reflects what actually occurred in session. If using AutoNotes, edit the draft so it matches your voice, your clinical judgment, and the client’s record.
Build cleaner stimulant-related notes with clinician-controlled AI
F15-related documentation can involve more than a single diagnosis label. Clinicians often need to capture stimulant use patterns, co-occurring symptoms, functional impairment, risk assessment, treatment plan progress, and next steps in one clear note.
AutoNotes can help by creating structured drafts for progress notes, intakes, assessments, and treatment plans while keeping you responsible for review and final approval. If you want a faster starting point for behavioral health documentation, start your free trial and test AutoNotes with your own documentation workflow.
